Pharmalot's Silverman moves to FDC Reports

Share this article:

Pharmalot blogger Ed Silverman is moving to Elsevier's Windhover/FDC Reports division, which publishes The Pink Sheet and In Vivo, after taking a buyout from the site's publisher, The Star-Ledger of New Jersey.

The beat reporter-turned-blogger, one of the top journalists covering the pharma industry, will serve as an editor at the Elsevier Business Intelligence unit starting next week. He'll contribute to various print and online titles and maybe even do some blogging.

In June, the Star-Ledger's owner, Newhouse Newspapers' Advance Publications, said it would sell the paper if it failed to win union concessions and buyouts of 200 of the title's 756 non-union employees, which included newsroom staff. 

Share this article:

Email Newsletters

More in News

Sanofi expands Gaucher disease portfolio

Sanofi expands Gaucher disease portfolio

The oral medication Cerdelga joins Cerezyme in its Fabry disease arsenal. Sanofi expects the drug will be priced "on par" with Cerezyme, which goes for around $300,000 a year in ...

Amicus seeks to upset Fabry market

Amicus seeks to upset Fabry market

Phase-III tests indicate patients may be able to switch from injectable enzyme-replacement therapies, like Fabrazyme, to the firm's oral drug.

Five things for pharma marketers to know: Wednesday, August 20

Five things for pharma marketers to know: Wednesday, ...

Novartis explores the virtual care space, a court has dismissed a lawsuit against IPAB, Doctors Without Borders calls the Ebola outbreak "a complete disaster" and Pfizer becomes the first pharma ...